ArticlePloS one2023

Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders.

Hila Magen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.